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Available pharmacologicaltreatments for Alzheimer disease (AD) have limited eﬀectiveness, are expensive, and sometimes induce
side eﬀects. Therefore, alternative or complementary adjuvant therapeutic strategies have gained increasing attention. The devel-
opment of novel noninvasive methods of brain stimulation has increased the interest in neuromodulatory techniques as potential
therapeutic tool for cognitive rehabilitation in AD. In particular, repetitive transcranial magnetic stimulation (rTMS) and
transcranial direct current stimulation (tDCS) are noninvasive approaches that induce prolonged functional changes in the
cerebral cortex. Several studies have begun to therapeutically use rTMS or tDCS to improve cognitive performances in patients
with AD. However, most of them induced short-duration beneﬁcial eﬀects and were not adequately powered to establish evidence
for therapeutic eﬃcacy. Therefore, TMS and tDCS approaches, seeking to enhance cognitive function, have to be considered still
very preliminary. In future studies, multiple rTMS or tDCS sessions might also interact, and metaplasticity eﬀects could aﬀect the
outcome.
1.Introduction
Given the limited eﬃcacy of pharmacological treatments [1],
nonpharmacological approaches in AD are of great interest.
In recent years, new techniques for studying the human
brain that allow for the noninvasive neurostimulation have
emerged. In particular, two techniques of noninvasive
brain stimulation—repetitive transcranial magnetic stimu-
lation (rTMS) and transcranial direct current stimulation
(tDCS)—arecapable for modulating cortical excitability and
inducing lasting eﬀects [2, 3]; both have been shown to have
potential therapeutic eﬃcacy in cognitive neuroscience [4].
By using rTMS, depending on the location and the stimula-
tion parameters as well as on the physiology of the under-
lying cortical tissue, behavioural changes may also be seen,
includingenhancement of orinterference with cognitiveper-
formance [5, 6]. rTMS has been increasingly utilized for var-
ious neurological [7–9] and psychiatric conditions [10–12].
tDCShasalso beenshown toinducecognitiveimprovements
in healthy subjects [13–15] and patients with neuropsy-
chiatric disorders such as depression [16–18], Parkinson
disease [19, 20], and stroke [21]. Both neuromodulatory
techniquescan inducelasting modulation ofbrain activity in
the targeted brain region and across brain networks through
transcranial inductionofelectric currentsin the brain[4].In
the last years, these two neuromodulatory techniques have
been proposed as a possible treatment to improve cognitive
performances, also in subjects aﬀected by dementia in which
it may represent a useful tool for cognitive rehabilitation.
2.TherapeuticInterventions
2.1. Neuromodulatory Techniques. rTMS is a technique that
deliverssingleTMSpulsesintrainswithaconstantfrequency
and intensity for a given time. tDCS is another simple and2 International Journal of Alzheimer’s Disease
powerful tool to modulate brain activity, which delivers low-
intensity electrical currents (below the perceptual threshold,
1 to 2mA) over the scalp using two large saline-soaked
spongeelectrodes. The resulting constantelectricalﬁeld pen-
etrates the skull and inﬂuences neuronal function.
rTMS can be applied as continuous trains of low-fre-
q u e n c y( 1H z )o rb u r s t so fh i g h e r - f r e q u e n c y( ≥5Hz)rTMS,
while tDCS can be applied as anodal or cathodal stimulation
[4]. In general, low-frequency rTMS and cathodal tDCS are
thought to reduce, and high-frequency rTMS and anodal
tDCS to enhance excitability in the targeted cortical region.
However, it is not completely understood by which mecha-
nisms of action rTMS and tDCS can induce lasting eﬀects
on the brain. The physiologic impact of both techniques
involves synaptic plasticity, speciﬁcally long-term potentia-
tion (LTP) and long-term depression (LTD). A link between
theaftereﬀectsinduced byrTMS and theinduction ofsynap-
tic plasticity has been recently identiﬁed [22]. Similarly,
tDCS may modulate synaptic strength within the cortex,
with evidence pointing to the involvement of intracortical
neurons [23].
2.2. Repetitive Transcranial Magnetic Stimulation. A recent
meta-analysis of publications searching for the eﬀects of
rTMS on cognitive functions [24] found convincing data
supporting improvement in several cognitive functions, in-
cluding executive functions, learning, and memory.
It has been demonstrated in elderly subjects that rTMS
induces a transient improvement in the associative memory
task and that it is associated with recruitment of right
prefrontal and bilateral posterior cortical regions [25]. Three
studies have been carried out to assess the eﬀectsof rTMS on
naming and language performance in patients with probable
AD.
In two crossover, sham-controlled, single-session studies
[26, 27] rTMS was applied to the dorsolateral prefrontal cor-
tex (DLPFC) during the execution of naming tasks (on-line
rTMs). In the ﬁrst study, a signiﬁcantly improved accuracy
in action naming, but not in object naming, was found fol-
lowing high-frequency rTMS of eitherleft or right DLPFC in
each of the 15 examined patients [26]. In the second study
[27], the eﬀect of rTMS applied to the DLPFC on picture
naming was assessed in 24 AD patients with diﬀerentdegrees
of cognitive decline. The authors found that the results of
the previous study were replicated only in mild AD patients
(Mini-Mental-State-Examination (MMSE) ≥17/30); in con-
trast, in patients with moderate to severe AD (MMSE <
17/30), both action and object naming were facilitated after
bothleft and right DLPFC rTMS. The lack of eﬀectsof rTMS
on object naming in early-stage AD might be related to a
“ceiling” eﬀect; when object naming is impaired, such as in
moderate to severe AD patients, rTMS to the DLPFC results
in an improved performance also for this class of stimuli.
The rTMS eﬀect was bilateral both in mild and severe AD
patients. The bilateral facilitation eﬀect could be attributed
to the presence of compensatory mechanisms based on the
recruitment of right hemispheric resources to support the
residual naming performance.
In a later study, Cotelli et al. [28] aimed to investigate
whether the application of high-frequency rTMS to the
left DLPFC may lead to signiﬁcant facilitation of language
productionand/orcomprehensioninpatientswithmoderate
AD. Ten patients were randomly assigned to one of two
groups. The ﬁrst group underwent a 4-week real rTMS stim-
ulation protocol, while the second underwent a 2-week
placebo treatment, followed by 2-weeks of real rTMS stim-
ulation. rTMS intervention consisted of a total of 4 weeks
of daily stimulation. No signiﬁcant eﬀects were observed
on naming performance. However, a signiﬁcant eﬀect was
observed on auditory sentence comprehension after 2 weeks
of real rTMS sessions, as compared to sham. Two additional
weeks of daily rTMS sessions resulted in no further improve-
ments,butasigniﬁcantbeneﬁtonauditorysentencecompre-
hension was still detected 8 weeks after the end of the rTMS
intervention. An important ﬁnding was the absence of any
eﬀects on memory and executive functions. Therefore, these
results were thought to be speciﬁc to the language network,
and not due to a general, nonspeciﬁc eﬀect on cognitive pro-
cessing.
None of these three studies reports any side eﬀects of the
rTMS applications, but it is not clear what safety evaluations
(if any) were completed.
In another study, Ahmed et al. [29]a i m e dt oc o m p a r e
the long-term eﬃcacy of high- versus low-frequency rTMS,
applied bilaterally over the DLPFC, on cortical excitability
and cognitive function of AD patients. The high-frequency
rTMS group improved signiﬁcantly more than the low-
frequency and sham groups in all assessed rating scales
(MMSE, Instrumental Daily Living Activity Scale and the
Geriatric Depression Scale)at all time pointsafter treatment.
Theimprovementwas maintainedfor3months. Theauthors
thus concluded that high-frequency rTMS may be a useful
addition to therapy for the treatment of patients with mild
to moderate degree of AD.
Since cognitive training (COG) may improve cognitive
functions in AD, in a recent study Bentwich et al. [30]a i m e d
to obtain a synergistic eﬀect of rTMS interlaced with COG
(rTMS-COG) in patients with AD. Eight patients with mild
to moderate probable AD were subjected to daily rTMS-
COGsessions (5/week)for6weeks,followedbymaintenance
sessions (2/week) for additional 6 months. The following six
regions, located individually by MRI, were stimulated: Broca
and Wernicke (language functions), right and left DLPFC
(judgment,executivefunctions, and long-temmemory), and
right and left parietal somatosensory association cortex
(spatial and topographical orientation and praxias). COG
tasks were developed to ﬁt these regions. Primary outcome
measures were average improvement of Alzheimer Dis-
ease Assessment Scale-Cognitive (ADAS-cog) and Clinical
Global Impression of Change (CGIC); secondary objectives
were average improvement of MMSE, the ADAS-Activi-
ties of Daily Living (ADAS-ADL), Hamilton Depression
Scale (HAMILTON),and Neuropsychiatric Inventory (NPI).
ADAS-cog improved by approximately 4 points after both 6
weeks and 4.5 months of treatment, and CGICby 1.0 and 1.6
points, respectively. MMSE, ADAS-ADL, and HAMILTON
improved, but without statistical signiﬁcance, while NPI didInternational Journal of Alzheimer’s Disease 3
not change. These ﬁndings provide direct evidence that
rTMS ishelpful in restoring brainfunctions and couldreﬂect
rTMS potential to recruit compensatory networks that
underliethememory-encoding andtheothercognitivefunc-
tions [31]. Therefore, rTMS-COG seems a promising and
safe modality for AD treatment.
2.3. Transcranial Direct Current Stimulation. Two crossover
designed studies using tDCS were performed to enhance
recognition memory in patients with AD [32, 33]. Because
temporoparietal areas are thought to be hypoactive in AD
[34], Ferrucci et al. [32] tested in a pilot study whether
anodal tDCS applied over temporoparietal cortex can in-
creasecorticalfunction,thusimprovingrecognitionmemory
in AD patients. They were delivered in 10 patients with mild
AD anodal tDCS, cathodal tDCS, and sham tDCS over bilat-
eral temporoparietal areas in three separate sessions (15min
at 1.5mA, at least 1 week apart). Anodal tDCS signiﬁcantly
improved recognition memory, cathodal tDCS signiﬁcantly
decreased accuracy in the word recognition task, sham tDCS
did not change it. Moreover, no eﬀects were observed in
a visual attention task, suggesting that the eﬀects of tDCS
were likely speciﬁc for recognition memory. Notably, no
safety considerations were reported. Boggio and colleagues
exposed patients with mild to moderately severe AD to a
session of anodal tDCS to the left DLPFC, anodal tDCS to
the left temporal cortex (cathode electrode was placed over
the right supraorbital area for these 2 sessions), or a session
of sham stimulation [33]. Since declarative memory is the
most aﬀected cognitive domain in AD patients, the aim of
this study was to investigate the impact of anodal tDCS on
recognition memory, working memory, and selective atten-
tion in AD.Sessions were 48h apart, and patients were tested
during each of the stimulation sessions, starting 10min after
stimulation onset and lasting until the end (30min at 2mA).
Stimulationoverboth prefrontal and temporal areas resulted
in a signiﬁcant improvement of visual recognition memory,
which was not attributable to a nonspeciﬁc attentional
process, as assessed by the Stroop task. On contrary, no
eﬀects were obtained on working memory.
This important study has several limitations. As the au-
thors themselves recognized, since a bipolar montage was
u s e d ,i tc a n n o tb ee x c l u d e dt h a tt h eo b s e r v e de ﬀects may
be the result of the stimulation from the reference electrode.
Moreover, the study did not measure whether the eﬀects of
the study were long lasting, and the authors did not perform
any other behavioural assessment to measure whether the
eﬀects observed in the study are clinically relevant. It should
be also considered that working memory was measured by a
digit span task, more indicative of attentional than working
memory function.
Interestingly, Scelzo and colleagues [35]f o u n da ni n -
creased short latency aﬀerent inhibition (SAI) after anodal
tDCS in 12 healthy subjects. SAI is a TMS protocol that may
give direct information about the function of some choliner-
gic pathways in the human motor cortex [36]. The enhance-
ment of cortical cholinergic circuits may thus represent an
important mechanism explaining anodal tDCS action in AD
and several other pathologic conditions.
3.Discussionand FuturePerspectives
The possible mechanisms that can account for the eﬀects of
rTMS and tDCS on cognitive performance conceivably re-
ﬂect the potential of these methods to improve the subject’s
ability to relearn or to acquire new strategies for carrying out
behavioural tasks.
The use of rTMS involves the discharge of a transient
electromagnetic ﬁeld through the skull. Electric currents are
induced in the brain by means of rapidly changing magnetic
ﬁelds; in turn, these determine transsynaptic depolarizations
of pools of neurons located in the superﬁcial cortical layers.
The capability of the rTMS to interact with the intrinsic
abilities of the brain to restore or compensate for damaged
function is a promise for possible applications in the ﬁeld
of cognitive rehabilitation. Since there is no clear knowledge
about spatial resolution of rTMS, it is diﬃcult to interpret
the observed functional eﬀects in terms of exact anatomical
eﬀects. The neurophysiological mechanisms responsible for
rTMS-induced facilitation remain unknown, even if they are
most likely related to the activation of impeded pathways
or inhibition of maladaptive responses. On the other hand,
rhythmic transcranial stimulation can exert positive eﬀects
on cognitive performance [37]. The modiﬁcation of cortical
activity through the use of rhythmic stimulation may read-
just pathological patterns of brain activity, thus providing an
opportunity to induce new, healthier activity patterns within
the aﬀected functional networks [38].
While rTMS elicits neuronal ﬁring, tDCS modulates the
spontaneousneuronalactivity[39].ThoughrTMSand tDCS
both yield similar eﬀects, tDCS has several practical advan-
tages over rTMS. Therefore, it is simpler, safer [40], and less
expensive and would be suitable for use in large series of
patients, possibly even at home. In fact, the above illustrated
ﬁndings prompt further studies using repeated tDCS, in
conjunctionwithothertherapeuticinterventionsfortreating
patients with AD. The prolonged aftereﬀects of tDCS are
probably due to synaptic [41] and nonsynaptic mechanisms
[42].
The eﬀects of tDCS might be related to a facilitation of
the corresponding brain area induced by the anodal elec-
trode; this neuronal network may become, consequently,
more reactive during the encoding phase of the task. The
DCS is thus responsible for priming the area to receive addi-
tional behavioural intervention.
These preliminary studies highlight the therapeutic po-
tential of the induction of long-term neuromodulatory ef-
fects using brain stimulation. They hold considerable pro-
mise, not only for advancing our understanding of brain
plasticity mechanisms, but also for designing new rehabilita-
tion strategies in patients with neurodegenerative disease.
Therefore, rTMS and tDCS might become useful in the
rehabilitation of AD patients. However, although promising,
results of noninvasive stimulation to enhance cognitivefunc-
tion in AD to date have to be considered extremely prelim-
inary. Most applications have been of short duration; the
eﬀects seem to be short lived and were not replicated
after longer-duration interventions. Conversely, some of the
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detected after single stimulation session [26–28]. Moreover,
bothtechniquesappearsafeinpatientswithAD,eveniflong-
term risks have been insuﬃciently considered.
On the other hand, the speciﬁc intervention that helps in
short-term studies may not help in long-term studies. For
all future studies a careful experimental design is needed
and patient selection aspects, stimulation parameters, and
clinical, cognitive, and behavioural assessment tools should
be considered. Of great importance is a careful choice of
outcomemeasures, also to enable comparison across studies.
It would also be valuable examining therapeutic eﬃcacy
of the neuromodulatory techniques in AD to employ the
neuropsychological battery of the Uniform Data Set (UDS)
or outcome scales commonly used in trials of pharmaco-
logical agents for AD, such as the Cognitive subscale of
the Alzheimer’s Disease Assessment Scale (ADAS-Cog) [43].
A n y w a y ,i ti sp o s s i b l et h a tt h ee ﬀects of the plasticity-based
interventions with high-frequency or anodal tDCS in the
brain of AD patients may diﬀer to those in normal subjects,
and studies to physiologically characterize this would be
important to guide future therapeutic trials.
It should be considered that most previous studies have
failed to be evidence based, and the assumption that cortical
plasticity enhancement is needed for the betterment of the
cognitive status of AD patients remains conjectural [43].
While TMS studies showed in AD cortical hyperexcit-
ability, the therapeutic attempts are based on techniques
aimed at increasing cortical excitability (anodal tDCS, high-
frequency rTMS). This hyperexcitability may be the conse-
quence of other underlying pathophysiologic mechanisms,
such as decreased synaptic eﬃciency or hypoplasticity.
Therefore, the cortical physiology seems to require more
solid investigation and should be appropriately tested before
and after therapeutic interventions. On the other hand, the
assumption that high-frequency rTMS will enhance cortical
excitability in AD patients may be wrong. Indeed, rTMS
eﬀects dependent on the state of activity of the brain at the
time of stimulation also remain debatable [44]. In addition,
the assumption that in AD the mechanisms of plasticity
might be abnormally reduced in the brain areas targeted
in the previous studies, the DLPFC or the temporoparietal
regions, has not been completely demonstrated.
Finally, improving performance in one task actually may
not necessarily represent cognitiveenhancement. More com-
prehensive outcome measures are needed to assess the clin-
ical signiﬁcance of rTMS or tDCS in AD and appropriately
powered studies with sound blinding procedures are neces-
sary [43]. It seems unlikely that stimulations over a single
brain area will contribute to a signiﬁcant improvement of
the cognitive status of AD patients, particularly those with
more advanced stages of disease. Multiple-target stimulation
protocols are necessary in order to overcome the multiple
cognitive deﬁcits characterizing moderate or severe AD.
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